Form C - Offering Statement:
SEC Accession No. 0001670254-25-000661
Filing Date
2025-06-20
Accepted
2025-06-18 21:07:01
Documents
11

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 11440
2 document_1.pdf EX-99 13330678
3 document_2.pdf EX-99 8464329
4 document_3.pdf EX-99 10150172
5 document_4.pdf EX-99 6441398
6 document_5.pdf EX-99 10145077
7 document_6.pdf EX-99 6441501
8 document_7.pdf EX-99 11186454
9 document_8.pdf EX-99 1174126
10 document_9.pdf EX-99 4854151
11 documents_list.htm EX-99 123
  Complete submission text file 0001670254-25-000661.txt   97062149
Mailing Address 223 WALL STREET, #130 HUNTINGTON NY 11743
Business Address 223 WALL STREET, #130 HUNTINGTON NY 11743 201-400-8083
SEN-JAM PHARMACEUTICAL INC. (Filer) CIK: 0001802249 (see all company filings)

EIN.: 822750291 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-36047 | Film No.: 251058811